Skip to content
Menu
CBD MEDICAL NETWORK
  • Das CBD Medical Network mit Infothek
  • Das Netzwerk („in incrementum“)
  • Kontakt
CBD MEDICAL NETWORK

Cannabidiol prescription in clinical practice

Posted on 18. Februar 202018. Februar 2020
PubMed

Research: Cannabidiol prescription in clinical practice: an audit on the first 400 patients in New Zealand

Graham Gulbransen, William Xu and Bruce Arroll (BJGP Open 4 February 2020)

Background: Cannabidiol (CBD) is the non-euphoriant component of cannabis. In 2017, the New Zealand Misuse of Drugs Regulations (1977) were amended, allowing doctors to prescribe CBD. Therapeutic benefit and tolerability of CBD remains unclear.

Aim: To review the changes in self-reported quality of life measurements, drug tolerability, and dose-dependent relationships in patients prescribed CBD oil for various conditions at a single institution.

Conclusion There may be analgesic and anxiolytic benefits of CBD in patients with non-cancer chronic pain and mental health conditions such as anxiety. CBD is well tolerated, making it safe to trial for non-cancer chronic pain, mental health, neurological, and cancer symptoms.

Direkt zur Studie

Unsere Info-Mails

Aktuelle Beiträge in der Infothek

  • TRPV1 schützt Neuronen bei Multipler Sklerose
  • CBD im Einsatz gegen CoVid.
  • Gedanken zu den ersten Cannabinoiden bzw. den Säure-Vorstufen
  • Das antimikrobielle Potenzial von Cannabidiol
  • Cannabigerol (CBG) aus pharmakologischer Sicht

Nach Stichworten suchen

Impressum & Datenschutz

Impressum & Datenschutz

Rechtliches

Impressum & Datenschutz

©2023 CBD MEDICAL NETWORK | Powered by WordPress and Superb Themes!